Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Zydus Walks Away From US Dapagliflozin Appeal, ANDA Discontinued
ANDA Sponsor And AstraZeneca Disagreed On Chances Of Settlement
Dec 06 2022
•
By
Dean Rudge
A raft of ANDAs are tentatively approved • Source: Faysal Farhan / Alamy Stock Photo
More from Generics
More from Products